Identification | Back Directory | [Name]
[1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide, 2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-[(5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl]-1-piperazinyl]-N-[2-methyl-4-(trifluoromethyl)phenyl]-7-oxo- | [CAS]
2869954-51-6 | [Synonyms]
Werner syndrome RecQ helicase-IN-2 [1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide, 2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-[(5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl]-1-piperazinyl]-N-[2-methyl-4-(trifluoromethyl)phenyl]-7-oxo- | [Molecular Formula]
C32H34F3N9O5 | [MOL File]
2869954-51-6.mol | [Molecular Weight]
681.66 |
Hazard Information | Back Directory | [Uses]
Werner syndrome RecQ helicase-IN-2 (example 57) is a potent Werner syndrome RecQ DNA helicase enzyme (WRN) inhibitor and can be used in cancer research[1]. | [References]
[1] Triazolo-pyrimidine analogues for treating diseases connected to the inhibiton of werner syndrome recq helicase (wrn). WO2022249060 |
|
|